UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine

Gene therapy, 2015-08, Vol.22 (8), p.628-635

2015

Volltextzugriff (PDF)

6149 POSTER Preliminary Results of a Phase 2-3 Clinical Study With the Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma (IMPACT Study)

European journal of cancer (1990), 2011, Vol.47, p.S437-S437

2011

Volltextzugriff (PDF)

Immunization of Cats against Feline Immunodeficiency Virus (FIV) Infection by Using Minimalistic Immunogenic Defined Gene Expression Vector Vaccines Expressing FIV gp140 Alone or with Feline Interleukin-12 (IL-12), IL-16, or a CpG Motif

Journal of Virology, 2000-11, Vol.74 (22), p.10447-10457

2000

Volltextzugriff (PDF)

DNA immunisation with minimalistic expression constructs

Vaccine, 2004-04, Vol.22 (13), p.1709-1716

2004

Volltextzugriff (PDF)

Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study

British journal of cancer, 1998-06, Vol.77 (11), p.1907-1916

1998

Volltextzugriff (PDF)

Safety, pharmacokinetics and pharmacodynamics from a clinical trial with healthy volunteers using the immunotherapeutic TLR-9 agonist MGN1703

Annals of oncology, 2015-11, Vol.26, p.viii5-viii5

2015

Volltextzugriff (PDF)

DNA-basierte Immuntherapie gegen Krebs

Arzneimittel-Forschung, 2012-12, Vol.62 (S 01), p.S11-S11

Schroff, M.

2012

Volltextzugriff (PDF)

1063PASET STUDY: FINAL RESULTS OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH MGN1601

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv366-iv367

2014

Volltextzugriff (PDF)

Aset Study: Final Results of Patients with Locally Recurrent or Metastatic Renal Cell Carcinoma (Rcc) Treated with Mgn1601

Annals of oncology, 2014-09, Vol.25, p.iv366

2014

Volltextzugriff (PDF)

High-performance micromotor control systems

IECON'03. 29th Annual Conference of the IEEE Industrial Electronics Society (IEEE Cat. No.03CH37468), 2003, Vol.1, p.347-352 vol.1

2003

Volltextzugriff (PDF)

The Novel Cancer Vaccine, Consisting of Genetically Modified Allogeneic Tumor Cells and Immunomodulator MGN1601: Updated Results of a Phase 1-2 Study in Patients with Advanced Renal Cell Carcinoma

Annals of oncology, 2012-09, Vol.23, p.ix268

2012

Volltextzugriff (PDF)

Preliminary safety data of an ongoing phase I-II clinical study with the tumor vaccine MGN1601 in patients with advanced renal cell carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15157-e15157

2011

Volltextzugriff (PDF)

Preliminary safety results of an ongoing phase I/II clinical study of MGN1601, a tumor vaccine comprising allogeneic, gene-modified, and irradiated tumor cells in combination with an immunomodulator in patients with metastatic renal cell carcinoma (ASET study)

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.392-392

2011

Volltextzugriff (PDF)

Preliminary results of an ongoing phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line induction therapy (IMPACT Study)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.618-618

2011

Volltextzugriff (PDF)

Transplantation of DBA/2 Mouse Corneas in BALB/c Recipients Significantly Delays Graft Rejection Compared with C3H Grafts and Facilitates Studies on Gene Transfer

The open transplantation journal, 2008-05, Vol.2 (1), p.9-12

2008

Volltextzugriff (PDF)

Safety data of MGN1601, a tumor vaccine, made of allogeneic, transfected, and irradiated tumor cells in combination with an immunomodulator for the treatment of metastatic renal cell carcinoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e15104-e15104

2010

Volltextzugriff (PDF)

Preclinical efficacy data of MGN1601, a tumor vaccine comprising 4-fold gene-modified and irradiated allogeneic tumor cells in combination with a DNA-based immunomodulator for the treatment of metastatic renal carcinoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e15067-e15067

2010

Volltextzugriff (PDF)

Up-regulation by feline interleukin-4 and down-regulation by feline interferon-gamma of major histocompatibility complex class II on cat B-lymphocytes

Veterinary immunology and immunopathology, 2002-09, Vol.88 (3), p.197-208

2002

Volltextzugriff (PDF)

Preliminary results of a phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line therapy: IMPACT study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14114-e14114

2011

Volltextzugriff (PDF)

A Novel Minimal-Size Vector (MIDGE) Improves Transgene Expression in Colon Carcinoma Cells and Avoids Transfection of Undesired DNA

Molecular therapy, 2001-05, Vol.3 (5), p.793-800

2001

Volltextzugriff (PDF)

Nuclear application of antisense oligonucleotides by microinjection and ballistomagnetic transfer to identify G protein heterotrimers activating phospholipase C

Methods in molecular biology (Clifton, N.J.), 1997, Vol.83, p.203

1997

Volltextzugriff (PDF)

Biologic Mesh Spacer Placement Facilitates Safe Delivery of Dose-intense Radiation Therapy: A Novel Treatment Option for Unresectable Liver Tumors

European journal of surgical oncology, 2016-10, Vol.42 (10), p.1591-1596

2016

Volltextzugriff (PDF)

Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide

Journal of molecular medicine (Berlin, Germany), 2001-06, Vol.79 (5-6), p.343-350

2001

Volltextzugriff (PDF)

Ballistic CTLA4 and IL-4 gene transfer into the lower lid prolongs orthotopic corneal graft survival in mice

Graefe's archive for clinical and experimental ophthalmology, 2003-11, Vol.241 (11), p.921-926

2003

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(118)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(139)
Deutsch
(7)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(57)
Humans
(46)
Biological And Medical Sciences
(31)
Male
(26)
Animals
(24)
Medical Sciences
(24)
Female
(20)
Adult
(18)
Immunology
(15)
Mice
(15)
Aged
(10)
Middle Aged
(10)
T-Lymphocytes - Immunology
(8)
Antibodies, Monoclonal - Immunology
(7)
Antibodies, Monoclonal - Therapeutic Use
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Genetic Vectors
(7)
Oncology
(7)
Aids/hiv
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine

6149 POSTER Preliminary Results of a Phase 2-3 Clinical Study With the Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma (IMPACT Study)

Immunization of Cats against Feline Immunodeficiency Virus (FIV) Infection by Using Minimalistic Immunogenic Defined Gene Expression Vector Vaccines Expressing FIV gp140 Alone or with Feline Interleukin-12 (IL-12), IL-16, or a CpG Motif

DNA immunisation with minimalistic expression constructs

Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study

Safety, pharmacokinetics and pharmacodynamics from a clinical trial with healthy volunteers using the immunotherapeutic TLR-9 agonist MGN1703

DNA-basierte Immuntherapie gegen Krebs

1063PASET STUDY: FINAL RESULTS OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH MGN1601

Aset Study: Final Results of Patients with Locally Recurrent or Metastatic Renal Cell Carcinoma (Rcc) Treated with Mgn1601

High-performance micromotor control systems

The Novel Cancer Vaccine, Consisting of Genetically Modified Allogeneic Tumor Cells and Immunomodulator MGN1601: Updated Results of a Phase 1-2 Study in Patients with Advanced Renal Cell Carcinoma

Preliminary safety data of an ongoing phase I-II clinical study with the tumor vaccine MGN1601 in patients with advanced renal cell carcinoma

Preliminary safety results of an ongoing phase I/II clinical study of MGN1601, a tumor vaccine comprising allogeneic, gene-modified, and irradiated tumor cells in combination with an immunomodulator in patients with metastatic renal cell carcinoma (ASET study)

Preliminary results of an ongoing phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line induction therapy (IMPACT Study)

Transplantation of DBA/2 Mouse Corneas in BALB/c Recipients Significantly Delays Graft Rejection Compared with C3H Grafts and Facilitates Studies on Gene Transfer

Safety data of MGN1601, a tumor vaccine, made of allogeneic, transfected, and irradiated tumor cells in combination with an immunomodulator for the treatment of metastatic renal cell carcinoma

Preclinical efficacy data of MGN1601, a tumor vaccine comprising 4-fold gene-modified and irradiated allogeneic tumor cells in combination with a DNA-based immunomodulator for the treatment of metastatic renal carcinoma

Heterozygous missense variants of LMX1A lead to nonsyndromic hearing impairment and vestibular dysfunction

Up-regulation by feline interleukin-4 and down-regulation by feline interferon-gamma of major histocompatibility complex class II on cat B-lymphocytes

Preliminary results of a phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line therapy: IMPACT study

A Novel Minimal-Size Vector (MIDGE) Improves Transgene Expression in Colon Carcinoma Cells and Avoids Transfection of Undesired DNA

Nuclear application of antisense oligonucleotides by microinjection and ballistomagnetic transfer to identify G protein heterotrimers activating phospholipase C

Biologic Mesh Spacer Placement Facilitates Safe Delivery of Dose-intense Radiation Therapy: A Novel Treatment Option for Unresectable Liver Tumors

Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide

Ballistic CTLA4 and IL-4 gene transfer into the lower lid prolongs orthotopic corneal graft survival in mice

Suchergebnisse filtern